Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1434-9949
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR ; day:17 ; month:4 ; year:2019 ; pages:1-11
Clinical rheumatology ; (17.4.2019), 1-11
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Ranza, Roberto
Vega, Maria Celina de la
Laurindo, Ieda Maria Magalhães
Gómez, Marìa Gimena
Titton, David Cezar
Kakehasi, Adriana Maria
Brigante, Alejandro
Benitez, Alejandro
Ranzolin, Aline
Granel, Amelia
Cappuccio, Ana María
Quinteros, Ana
Hayata, André Luiz Shinji
Smichowski, Andrea
Duarte, Ângela Luzia Branco P.
Kahlow, Barbara Stadler
Andia, Carolina Sánchez
Brenol, Claiton Viegas
Velozo, Edson
Mussano, Eduardo
Soriano, Enrique R.
Christopoulos, Georges Basile
Rocha Castelar Pinheiro, Geraldo da
Castro, Gláucio Ricardo Werner de
Casado, Gustavo
Silveira Carvalho, Hellen Mary da
Exeni, Ida Elena
Silveira, Inês Guimarães da
Petkovic, Ingrid
Pereira, Ivanio Alves
Costa, Izaias Pereira da
Rosa, Javier Eduardo
Miranda, José Roberto Silva
Moraes, Julio Cesar Bertacini de
Bertolo, Manoel Barros
Buhl, Manuel
Lázaro, Maria Alícia
Sauma, Maria de Fátima Lobato C. da
Medeiros Pinheiro, Marcelo de
Díaz, Monica
Vechi, Mônica Valéria Siqueira Santana de
Cerda, Osvaldo Luis
Astesana, Pablo
Curi, Pablo Finucci
Louzada-Jr, Paulo
Teodoro, Reginaldo Botelho
Toledo, Roberto Acayaba
Papasidero, Sílvia
Valim, Valeria
Fernandes, Vander
Saurit, Veronica
Bianchi, Washington Alves
Melo Costa Pinto, Rogério de
Descalzo, Miguel Angel
Gomez-Reino, Juan Jesus
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10067-019-04516-2
- URN
-
urn:nbn:de:101:1-2019052119261011144401
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ranza, Roberto
- Vega, Maria Celina de la
- Laurindo, Ieda Maria Magalhães
- Gómez, Marìa Gimena
- Titton, David Cezar
- Kakehasi, Adriana Maria
- Brigante, Alejandro
- Benitez, Alejandro
- Ranzolin, Aline
- Granel, Amelia
- Cappuccio, Ana María
- Quinteros, Ana
- Hayata, André Luiz Shinji
- Smichowski, Andrea
- Duarte, Ângela Luzia Branco P.
- Kahlow, Barbara Stadler
- Andia, Carolina Sánchez
- Brenol, Claiton Viegas
- Velozo, Edson
- Mussano, Eduardo
- Soriano, Enrique R.
- Christopoulos, Georges Basile
- Rocha Castelar Pinheiro, Geraldo da
- Castro, Gláucio Ricardo Werner de
- Casado, Gustavo
- Silveira Carvalho, Hellen Mary da
- Exeni, Ida Elena
- Silveira, Inês Guimarães da
- Petkovic, Ingrid
- Pereira, Ivanio Alves
- Costa, Izaias Pereira da
- Rosa, Javier Eduardo
- Miranda, José Roberto Silva
- Moraes, Julio Cesar Bertacini de
- Bertolo, Manoel Barros
- Buhl, Manuel
- Lázaro, Maria Alícia
- Sauma, Maria de Fátima Lobato C. da
- Medeiros Pinheiro, Marcelo de
- Díaz, Monica
- Vechi, Mônica Valéria Siqueira Santana de
- Cerda, Osvaldo Luis
- Astesana, Pablo
- Curi, Pablo Finucci
- Louzada-Jr, Paulo
- Teodoro, Reginaldo Botelho
- Toledo, Roberto Acayaba
- Papasidero, Sílvia
- Valim, Valeria
- Fernandes, Vander
- Saurit, Veronica
- Bianchi, Washington Alves
- Melo Costa Pinto, Rogério de
- Descalzo, Miguel Angel
- Gomez-Reino, Juan Jesus
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Recource Registries
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: can we make better use of patient data registries?
eRegistries: Electronic registries for maternal and child health
Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy
Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Recource Registries
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: can we make better use of patient data registries?
eRegistries: Electronic registries for maternal and child health
Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy
Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Recource Registries
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: can we make better use of patient data registries?
eRegistries: Electronic registries for maternal and child health